NCT05249634View on ClinicalTrials.gov

Testosterone Treatment in Men with Chronic Kidney Disease

PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions

Hypogonadism, MaleKidney Disease, Chronic

Interventions

DRUG

Jatenzo Pill

oral tablet daily

Trial Locations (1)

63104

RECRUITING

Saint Louis Univeristy, St Louis

Sponsors

Collaborators (1)

Clarus Therapeutics, Inc.

All Listed Sponsors

collaborator

Clarus Therapeutics, Inc.

INDUSTRY

lead

St. Louis University

OTHER

NCT05249634 - Testosterone Treatment in Men with Chronic Kidney Disease | Biotech Hunter | Biotech Hunter